Compare GLP & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GLP | ENOV |
|---|---|---|
| Founded | 2005 | 1995 |
| Country | United States | United States |
| Employees | 4700 | N/A |
| Industry | Oil Refining/Marketing | Fluid Controls |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | N/A | 2008 |
| Metric | GLP | ENOV |
|---|---|---|
| Price | $44.77 | $22.64 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $46.00 | ★ $48.75 |
| AVG Volume (30 Days) | 36.9K | ★ 795.4K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.93% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $64.13 | $6.36 |
| Revenue Next Year | $11.74 | $5.31 |
| P/E Ratio | $23.28 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $39.58 | $21.00 |
| 52 Week High | $56.51 | $36.82 |
| Indicator | GLP | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 42.59 | 48.33 |
| Support Level | $40.54 | $21.33 |
| Resistance Level | $45.74 | $23.57 |
| Average True Range (ATR) | 1.69 | 1.13 |
| MACD | -0.38 | 0.02 |
| Stochastic Oscillator | 48.79 | 45.72 |
Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the GDSO segment.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.